ALLINOVI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.839
EU - Europa 1.474
AS - Asia 411
AF - Africa 9
SA - Sud America 4
Totale 3.737
Nazione #
US - Stati Uniti d'America 1.830
RU - Federazione Russa 714
IT - Italia 271
IE - Irlanda 123
SG - Singapore 119
PL - Polonia 111
HK - Hong Kong 105
CN - Cina 96
SE - Svezia 96
CH - Svizzera 37
JO - Giordania 35
FI - Finlandia 28
IN - India 27
DE - Germania 21
GB - Regno Unito 17
KR - Corea 12
RO - Romania 12
BE - Belgio 11
FR - Francia 9
VN - Vietnam 8
CA - Canada 7
GR - Grecia 6
NL - Olanda 6
AT - Austria 5
CI - Costa d'Avorio 5
BF - Burkina Faso 3
ES - Italia 3
ID - Indonesia 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
EC - Ecuador 2
MT - Malta 2
BY - Bielorussia 1
IR - Iran 1
MU - Mauritius 1
MX - Messico 1
PA - Panama 1
UA - Ucraina 1
Totale 3.737
Città #
Santa Clara 713
Fairfield 137
Dublin 121
Chandler 120
Warsaw 111
Singapore 105
Ashburn 93
Hong Kong 81
Ann Arbor 71
Seattle 66
Woodbridge 52
Florence 51
Houston 44
Cambridge 36
Wilmington 36
Bern 35
Moscow 34
Altamura 29
Lawrence 29
New York 26
Princeton 24
Shanghai 22
Helsinki 21
Beijing 18
Buffalo 17
Boston 16
Kent 16
Milan 15
Medford 12
Mumbai 12
Timisoara 12
Brussels 11
San Diego 10
West Jordan 10
London 9
Seoul 9
Boardman 8
Los Angeles 8
Ahmedabad 7
Palermo 7
Dong Ket 6
Lappeenranta 6
Yubileyny 6
Abidjan 5
Carmignano 5
Padova 5
Washington 5
Guangzhou 4
Munich 4
Naples 4
Pisa 4
Redwood City 4
Rome 4
Toronto 4
Vienna 4
Zhengzhou 4
Arezzo 3
Dearborn 3
Falls Church 3
Hillsboro 3
Jacksonville 3
Jakarta 3
Jiaxing 3
Marano Di Napoli 3
Ottawa 3
Ouagadougou 3
Prato 3
Pune 3
San Jose 3
Siena 3
Xi'an 3
Alghero 2
Andover 2
Anghiari 2
Barletta 2
Beilngries 2
Cagliari 2
Campi Bisenzio 2
Capannori 2
Castelliri 2
Chicago 2
Chuzhou 2
Corciano 2
Deiva Marina 2
Fondi 2
Genoa 2
Guayaquil 2
Kochi 2
Melita 2
Montepulciano 2
Málaga 2
Novara 2
Nuremberg 2
Paris 2
Redmond 2
Scarperia e San Piero 2
Seravezza 2
Toulouse 2
Villa Literno 2
Wuhan 2
Totale 2.431
Nome #
Can serum and urinary biomarkers predict acute kidney injury after robotic partial nephrectomy? a prospective feasibility study 180
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab 175
Urinary [TIMP-2]/[IGFBP7] Ratio (Nephrocheck ® akiscore ®) as a biomarker of “subclinical” acute kidney injury after robotic partial nephrectomy 172
NephroCheck™ and kinetic GFR as promising markers for the early detection of acute kidney injury after partial nephrectomy: Preliminary results from a single-centre prospective study 169
ANCA-associated vasculitis in childhood: Recent advances 167
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. 166
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 144
Evaluation of different biomarkers for the early detection of acute kidney injury following elective nephron-sparing surgery: Preliminary results in a prospective cohort study 135
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 124
Regenerating the kidney using human pluripotent stem cells and renal progenitors 115
Lung ultrasound: a novel technique for detecting fluid overload in children on dialysis 115
Anti-fibrotic treatments: A review of clinical evidence 106
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 95
Perioperative use of serum creatinine and postoperative acute kidney injury: a single-centre, observational retrospective study to explore physicians' perception and practice 91
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 90
Correction: Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 89
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 87
The Predictive Role of Biomarkers for the Detection of Acute Kidney Injury After Partial or Radical Nephrectomy: A Systematic Review of the Literature 86
Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease 84
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 80
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 77
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 75
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 75
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 71
Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis 69
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry 65
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 63
Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis 62
Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy 61
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 61
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 60
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 59
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 59
Doppler-Derived Renal Functional Reserve in the Prediction of Postoperative Acute Kidney Injury in Patients Undergoing Robotic Surgery 58
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 58
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 57
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment—A Literature Review 55
Screening for cardiac amyloidosis in patients with tenosynovial red flags: A collaboration between family medicine and cardiology 53
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series 53
Presentation and progression of MPO-ANCA interstitial lung disease 47
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 46
Late initiation of anakinra can induce complete renal response in renal AA amyloidosis secondary to Familial Mediterranean Fever. 20
To B or not to B. The rationale for quantifying B-lines in pediatric lung diseases 20
Totale 3.794
Categoria #
all - tutte 13.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 39 41 31 40 38 19 15
2020/2021316 14 40 41 24 32 20 22 21 24 47 17 14
2021/2022238 10 2 10 12 8 17 11 18 14 28 38 70
2022/2023627 44 100 31 42 37 91 87 47 61 16 31 40
2023/2024459 5 31 52 29 36 70 21 107 4 48 40 16
2024/20251.808 78 254 139 444 637 256 0 0 0 0 0 0
Totale 3.794